VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
VBI Vaccines reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
VBI Vaccines reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, three executives at VBI Vaccines received on average a compensation package of $1.1M, a 6% decrease compared to previous year.
Average pay of disclosed executives at VBI Vaccines
Jeffrey R. Baxter, Chief Executive Officer, received $1.4M in total, which decreased by 8% compared to 2018. 47% of Baxter's compensation, or $644K, was in option awards. Baxter also received $175K in bonus, $500K in salary, as well as $61K in other compensation.
Francisco Diaz-Mitoma, Chief Medical Officer, received a compensation package of $917K, which decreased by 4% compared to previous year. 47% of the compensation package, or $429K, was in option awards.
David E. Anderson, Chief Scientific Officer, earned $882K in 2019, a 4% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2020.